Home >> CI Services >> Regulatory Updates Monitoring >> Case Studies
REGULATORY GUIDELINES MONITORING

Ensuring Market Readiness in
Advanced Therapy Development

A mid-sized cell and gene therapy developer leveraged our regulatory guideline monitoring framework to fast-track pipeline progress and gain competitive advantage.

Let's Talk
The Challenge

Tracking the Regulatory Shifts to Keep-up with the Industry

Fragmented Oversight

The client, a cell and gene therapy developer for rare disorders, lacked a structured lens to track disparate manufacturing (CMC) standards across the US, European Union and Asia-Pacific.

Unclear Submission Drivers

Internal metrics and regulatory protocol tracking failed to explain why similar therapies were receiving Complete Response Letters (CRLs) for data integrity issues.

Limited Strategic Clarity

In a crowded innovation market, the client struggled to adapt its clinical design based on real-time regulatory shifts rather than static assumptions.

The Roots Way

How Roots Helped?

In order to up-shift regulatory adherence, Roots Analysis built a structured regulatory intelligence process integrating data from health authority databases, clinical trial registries and committee meetings.
Surveillance & Sanitization: We designed a framework to map major global regulatory portals, collating real-time updates and removing irrelevant policy updates / noise.
Expert Sentiment Assessment: Based on our in-house expertise, we processed committee meeting transcripts and interviews to generate user-specific insights on agency concerns regarding efficacy and long-term safety of advanced therapies.
Identifying Strategic Gaps: The insights identified specific gaps in the client’s chemistry, manufacturing and controls documentation, suggesting low-effort, quick-win adjustments that significantly strengthened the BLA submission package.
Change We Created

Results You Can Quantify & Impact
Our Clients Can Count On

27%
Drop in Regulatory Queries
By leveraging real-time regulatory updates, the client achieved 27% decrease in follow-up clarification requests from health authorities due to proactive "pre-filing" alignment
24%
Increased Submission Speed
Owing to an elaborate protocol alignment framework, the client could improve first-to-file timelines by 24% as compared to peers by anticipating new guidelines earlier
16%
Market Share Impact
Proactive monitoring of regulatory shifts and identifying future changes led to a 16% increase in market share. The improvement further drove investor confidence metrics as a result of a transparent, "de-risked" regulatory roadmap

Want to Start?

READ MORE CASE STUDIES

Explore How We Helped Others